Moderate Bulk & Strength Endurance Cycle
- Brand: Ultima Pharmaceuticals - Cycles
- Product Code: Moderate Bulk & Strength Endurance Cycle
- Availability: In Stock
-
$196.00
**1 x Ultima-Enan 250** - Ultima Pharmaceuticals [10 ml x 250 mg/ml]
**3 x Ultima-Bold** - Ultima Pharmaceuticals [10 ml x 250 mg/ml]
**2 x Ultima-Clen-Salbuto** - Ultima Pharmaceuticals [50 pills x 2 mg]
**1 x Ultima-Nolva** - Ultima Pharmaceuticals [50 pills x 20 mg]
MANUFACTURER
Ultima Pharmaceuticals - Cycles
WAREHOUSE
International Warehouse 3
SUBSTANCE
Boldenone Undecylenate, Tamoxifen Citrate, Testosterone Enanthate, Salbutamol
Unlock your potential with this expertly crafted stack, ideal for individuals aiming for moderate muscle gains and enhanced strength endurance. Perfectly suited for athletes involved in boxing and contact sports, this cycle helps you maintain peak speed and stamina. At the heart of this powerful stack is Boldenone, a slower-acting anabolic agent that delivers well-defined, substantial gains. To keep estrogen-related side effects and water retention in check, we recommend incorporating Testosterone Propionate.
Testosterone forms a solid foundation as the secondary steroid in this stack, allowing for lower dosage requirements while enhancing overall effectiveness. The combination of Testosterone and Boldenone is not only safe but also minimizes the risk of significant liver toxicity, making it unnecessary to use Aromatase Inhibitors during the cycle. Users can expect to gain up to 16 pounds of quality muscle in just 8 weeks, promoting moderate muscle growth alongside high-speed performance.
- **Ultima-Enan 250**: 250 mg per week - **Ultima-Bold**: 600-800 mg per week
Dosage:Combine Ultima-Nolva and Ultima-Clen-Salbuto for a duration of 3 weeks.
Post Cycle Therapy (PCT):Please remember, we are not professionals; our insights are based on personal experiences and should not replace expert guidance. OSGear disclaims any responsibility for issues arising from the cycle, improper product administration, or unexpected results.

